✦ LIBER ✦

A534 Perifosine: Final Results of a Phase II Trial in Relapsed/Refractory Waldenström Macroglobulinemia

✍ Scribed by Ghobrial, IM; Roccaro, AM; Sportelli, P; Treon, SP; Weller, E; Leleu, X; Rubin, N; Hong, F; Leduc, R; Chuma, S; Nelson, M; C'Connor, K; Sam, A; Harris, B; Warren, D; Anderson, KC; Richardson, PG

Book ID: 118629388
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 85 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.1016/s1557-9190(11)70615-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A535 Phase II Trial of Bortezomib and Ri

A535 Phase II Trial of Bortezomib and Rituximab in Relapsed/Refractory Waldenström Macroglobulinemia

✍ Ghobrial, IM; Roccaro, AM; Matous, J; Padmanabhan, W; Badros, A; Schlossman, R; 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 112 KB

A533 RAD001: Phase II Trial in Relapsed/

A533 RAD001: Phase II Trial in Relapsed/Refractory Waldenström Macroglobulinemia, the DFCI Experience

✍ Ghobrial, IM; Roccaro, AM; Chuma, S; Sam, AP; Leduc, R; Nelson, M; O'Connor, K; 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 103 KB

Early Results of a Phase I Trial of Obli

Early Results of a Phase I Trial of Oblimersen Sodium for Relapsed or Refractory Waldenström's Macroglobulinemia

✍ Gertz, Morie A.; Geyer, Susan M.; Badros, Ashraf; Kahl, Brad S.; Erlichman, Char 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 95 KB

Atacicept in relapsed/refractory multipl

Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study

✍ Rossi, J-F; Moreaux, J; Hose, D; Requirand, G; Rose, M; Rouillé, V; Nestorov, I; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 287 KB

A347 Phase I Trial of Perifosine, Lenali

A347 Phase I Trial of Perifosine, Lenalidomide, and Dexamethasone in Relapsed or Refractory Myeloma

✍ Jakubowiak, AJ; Hideshima, T; Sportelli, P; Gardner, L; Giusti, K; Richardson, P 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 111 KB

Extended follow-up of a phase II trial i

Extended follow-up of a phase II trial in relapsed, refractory multiple myeloma: : Final time-to-event results from the SUMMIT trial

✍ Paul G. Richardson; Bart Barlogie; James Berenson; Seema Singhal; Sundar Jaganna 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 2 views